Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease in the United States: Results From the 2017 National Health Interview Survey
Why the study?
Recent trials (ASCEND, ARRIVE, and ASPREE) showed few benefits and consistent bleeding risks with aspirin for primary prevention of CVD, contrasting with prior wide support.
Population
Participants in the 2017 National Health Interview Survey in the United States
Comparison
Aspirin use vs non-use for primary prevention of CVD
Design
Survey-based cross-sectional study
Authors
Discussion
Loading...
Member takes
Implication
Offers prevalence estimates of aspirin for primary prevention; leaves open alignment with updated guidelines.
Structured PICO
P
Population
United States population (from the 2017 National Health Interview Survey)
I
Intervention
Aspirin use for primary prevention of cardiovascular disease
O
Outcome
Prevalence of aspirin use
Cite This Study
O'Brien et al. (2019) studied this question.